- Works count
- 1,440
- Citation count
- 29,102
- H-index
- 70
- i10-index
- 314
Research interests
Publications
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · 10.1056/nejmoa1509388
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Blood · 2013 · 10.1182/blood-2013-05-501569
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.
The Lancet Oncology · 2011 · 10.1016/s1470-2045
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
The Lancet · 2010 · 10.1016/s0140-6736(10)61381-5
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
New England Journal of Medicine · 2010 · 10.1056/nejmoa1002315
Current projects
No projects listed.